Use of avacopan with a lower dose of glucocorticoids leads to fewer total and serious side effects, as well as infections.

In 2019, the age-adjusted prevalence for vasculitis per 1,000,000 Alaska Native and American Indian adults was 752 (95% CI, 581-959). The prevalence of antineutrophil cytoplasmic antibody-associated ...

Avacopan was safe and effective among patients with respiratory tract manifestations of antineutrophil cytoplasmic antibody-associated vasculitis. Researchers performed a post hoc analysis of the ...

Nellie Zygiel of Fairhaven was diagnosed over a decade ago with a rare disease, GPA Vasculitis. She has faced other health challenges over her young life. Vasculitis can affect the kidneys ...

The final months of 2024 saw Nkarta launch two trials of NKX019: in lupus nephritis as well as in in systemic sclerosis, idiopathic inflammatory myopathy and ANCA-associated vasculitis.